PATENT CLAIM ANALYSIS

Application Number: 15973110
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "419000"]

Abstract:
Indolinone derivative compounds that act as EWS-FLI1 transcription factor inhibitors are provided. Also provided are pharmaceutical compositions of the indolinone derivatives, methods of synthesizing the same, methods of treating using same, and assays for identifying the inhibitors of EWS-FLI1 oncoprotein.

Claim (Index 18):
The method of  claim 17 , wherein the cell is a cancer cell, wherein the cancer is selected from the group consisting of Ewing's sarcoma, prostate cancer, glioblastoma, acute myeloid leukemia, breast cancer, head cancer, neck cancer, melanoma, non-small cell lung cancer, ovarian cancer, and uterine cancer.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.45161
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15357876', '15357933', '14877708', '15461327', '15680905']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8030649841558768
- 35 USC 102 Novelty (BERT): 0.5968709268709618
- Combined Prediction Score: 0.7824455784273853
- Mean Citation Score: 449.132644
- Max Citation Score: 536.8392
- Similarity Product: 434.5828724543096

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test